Energy News / Shareholders Foundation, Inc.

NASDAQ:MBVX Shareholder Notice: Lawsuit Alleges Misleading Statements by MabVax Therapeutics Holdings, Inc

Via: ReleaseWire

Updated 11:30 AM CDT, Tue, June 19,2018

A lawsuit was filed on behalf of investors in MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX) shares over alleged securities laws violations.

San Diego, CA -- (SBWIRE) -- 06/19/2018 -- An investor, who purchased shares of MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX), filed a lawsuit over alleged violations of Federal Securities Laws by MabVax Therapeutics Holdings, Inc. in connection with certain allegedly false and misleading statements.

Investors who shares of MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX) have certain options and for certain investors are short and strict deadlines running. Deadline: August 3, 2018. NASDAQ:MBVX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff claims that between March 14, 2016 and May 18, 2018, the defendants failed to disclose, that the Company's internal controls over financial reporting were materially weak and deficient, that the Company had incorrectly calculated and reported beneficial ownership of MabVax Therapeutics Holdings, Inc shares, and permitted improper influence or control over MabVax Therapeutics Holdings, Inc, and/or the Company's officers and directors by certain shareholders, and that that, as a result of the foregoing, the Company's financial statements and Defendants' statements about MabVax Therapeutics Holdings, Inc's business, operations, and prospects, were materially false and misleading at all relevant times.

Those who purchased shares of MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaqmbvx-shareholder-notice-lawsuit-alleges-misleading-statements-by-mabvax-therapeutics-holdings-inc-996968.htm

Media Relations Contact
Michael Daniels
858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com